U.S. advisers back Human Genome lupus drug

Published November 18, 2010

U.S. advisers back Human Genome lupus drug
A highly anticipated lupus treatment from Human Genome Sciences Inc moved closer to the U.S. market on Tuesday with an endorsement from a government advisory panel.
Read more on Reuters via Yahoo! News

FDA Advisers Endorse New Lupus Drug
TUESDAY, Nov. 16 (HealthDay News) — U.S. Food and Drug Administration advisers voted 13-2 Tuesday to recommend approval of the first new drug in more than 50 years to treat the autoimmune disease lupus.
Read more on HealthDay via Yahoo! News

New drug produces steep drop in bad cholesterol, boost to good
No Summary Available
Read more on Lubbock Avalanche-Journal